South Carolina Multistate Pharmacy Jurisprudence Examination (MPJE) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Prepare for the South Carolina MPJE with flashcards and multiple choice questions. Each question offers hints and explanations to enhance your understanding. Get exam-ready today!

Practice this question and more.


What happens if a patient requests to change the dosage form of a C2 medication?

  1. The prescription must be canceled

  2. The patient needs a new prescription

  3. The pharmacist can make the change after consulting a prescriber

  4. It is not allowed for C2 medications

The correct answer is: The pharmacist can make the change after consulting a prescriber

When a patient requests to change the dosage form of a Schedule II (C2) medication, the correct approach is for the pharmacist to consult with the prescriber before making any changes. This is because C2 medications are subject to strict regulations regarding their dispensing and modification due to their potential for abuse and dependence. Changing the dosage form of a C2 medication essentially alters the original prescription that was provided by the prescriber. Thus, to ensure that the change is medically appropriate and safe for the patient, it is crucial for the pharmacist to communicate with the prescriber. This safeguard helps maintain oversight over medications that require careful monitoring. In situations where such changes are made without prescriber consultation, it could lead to patient safety issues, incorrect dosing, or increased risk of abuse. Therefore, the involvement of the prescriber is a necessary step in ensuring that the patient's treatment plan is modified appropriately and safely. Other options do not align with the regulatory framework governing C2 medications. Cancelling the prescription outright or indicating that a new prescription is needed without consultation neglects the possibility of a safe and appropriate modification. Stating that it is not allowed entirely overlooks the role of prescriber-pharmacist communication in patient care.